PROTHENA CORP PUBLIC LTD CO
PRTADrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How PRTA's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NEOD001 | Phase 2 | Primary Amyloidosis | - | - |
Frequently asked questions
What is in PROTHENA CORP PUBLIC LTD CO's drug pipeline?→
CatalystAlert tracks 1 drug candidate in PROTHENA CORP PUBLIC LTD CO's (PRTA) pipeline across Phase 2. Its lead program is NEOD001 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PROTHENA CORP PUBLIC LTD CO's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PROTHENA CORP PUBLIC LTD CO (PRTA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PRTA biotech catalysts?→
Add PRTA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PROTHENA CORP PUBLIC LTD CO's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.